OncoSec Announces 2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
ONCSDelisted Stock | USD 0.06 0 3.63% |
Slightly above 61% of OncoSec Medical's investor base is looking to short. The analysis of current outlook of investing in OncoSec Medical suggests that many traders are alarmed regarding OncoSec Medical's prospects. OncoSec Medical's investing sentiment can be driven by a variety of factors including economic data, OncoSec Medical's earnings reports, geopolitical events, and overall market trends.
OncoSec |
OncoSec Medical Incorporated , a clinical-stage biotechnology company developing intratumoral immunotherapies to stimulate the patients immune system to target cancer cells and eradicate disease, today announced that it has entered into a definitive agreement for the purchase and sale of an aggregate of 1,582,932 shares of its common stock , at a purchase price of 1.25 per share or common stock equivalent
Read at finance.yahoo.com
OncoSec Medical Fundamental Analysis
We analyze OncoSec Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of OncoSec Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of OncoSec Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Book Value Per Share
Book Value Per Share Comparative Analysis
OncoSec Medical is currently under evaluation in book value per share category among its peers. Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
OncoSec Medical Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with OncoSec Medical stock to make a market-neutral strategy. Peer analysis of OncoSec Medical could also be used in its relative valuation, which is a method of valuing OncoSec Medical by comparing valuation metrics with similar companies.
Peers
OncoSec Medical Related Equities
ZVSA | ZyVersa Therapeutics | 5.19 | ||||
ALLR | Allarity Therapeutics | 1.94 | ||||
VRAX | Virax Biolabs | 1.87 | ||||
UNCY | Unicycive Therapeutics | 1.64 | ||||
IMMX | Immix Biopharma | 0.97 | ||||
ATNF | 180 Life | 1.27 | ||||
BDRX | Biodexa Pharmaceticals | 1.38 | ||||
REVB | Revelation Biosciences | 2.44 | ||||
QNRX | Quoin Pharmaceuticals | 3.39 | ||||
DRMA | Dermata Therapeutics | 4.32 | ||||
PHIO | Phio Pharmaceuticals | 4.81 | ||||
PALI | Palisade Bio | 10.84 |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in OncoSec Stock
If you are still planning to invest in OncoSec Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the OncoSec Medical's history and understand the potential risks before investing.
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Transaction History View history of all your transactions and understand their impact on performance | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Global Correlations Find global opportunities by holding instruments from different markets |